dipyridamole has been researched along with ascorbic acid in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (33.33) | 18.7374 |
| 1990's | 6 (33.33) | 18.2507 |
| 2000's | 2 (11.11) | 29.6817 |
| 2010's | 4 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Schulman, JD | 1 |
| Pascual, C; Romay, C | 1 |
| De la Cruz, JP; García, PJ; Sánchez de la Cuesta, F | 1 |
| Carrasco, T; de la Cruz, JP; Ortega, G; Sanchez de la Cuesta, F | 1 |
| Akhaladze, GG; Aref'ev, AE; Gal'perin, EI; Nasirov, FN; Sakevarashvili, GR; Tatishvili, GG | 1 |
| von Ardenne, M | 1 |
| Höllenriegel, K; Mundt, D; Schmähl, D | 1 |
| Beisenherz, G; Flanagan, M; Pelzer, H; Watanabe, Y | 1 |
| Saldan, IR | 1 |
| Häusl, B; Nolte, D | 1 |
| Chandy, T; Sharma, CP; Vasudev, SC | 1 |
| Horbatiuk, OM | 1 |
| Boonyen, M; Futrakul, N; Futrakul, P; Patumraj, S; Siriviriyakul, P; Tosukhowong, P | 1 |
1 review(s) available for dipyridamole and ascorbic acid
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for dipyridamole and ascorbic acid
| Article | Year |
|---|---|
[Effectiveness of "oxygen-multistep-therapy"].
Topics: Aged; Ascorbic Acid; Dipyridamole; Female; Humans; Isosorbide Dinitrate; Lung Diseases; Male; Middle Aged; Orotic Acid; Ouabain; Oxygen; Oxygen Inhalation Therapy; Partial Pressure; Sleep; Thiamine | 1980 |
16 other study(ies) available for dipyridamole and ascorbic acid
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Approaches to the treatment of inborn errors of sulphur amino acid and peptide metabolism.
Topics: Amino Acids, Sulfur; Ascorbic Acid; Aspirin; Cysteamine; Cystinosis; Dipyridamole; Glutathione; Glutathione Synthase; Homocystinuria; Humans; Metabolism, Inborn Errors; Pyridoxine; Vitamin E | 1979 |
Effect of antioxidants on chemiluminescence produced by reactive oxygen species.
Topics: Antioxidants; Ascorbic Acid; Catechin; Dipyridamole; Ditiocarb; Ferrous Compounds; Fluorometry; Free Radical Scavengers; Horseradish Peroxidase; Luminescent Measurements; Luminol; Oxygen; Peroxides; Superoxides; tert-Butylhydroperoxide; Vitamin E | 1992 |
Dipyridamole inhibits platelet aggregation induced by oxygen-derived free radicals.
Topics: Adult; Arachidonic Acid; Ascorbic Acid; Dipyridamole; Ferrous Compounds; Free Radicals; Humans; Lipid Peroxidation; Male; Platelet Aggregation; Pyrogallol; Superoxides | 1992 |
Inhibition of ferrous-induced lipid peroxidation by pyrimido-pyrimidine derivatives in human liver membranes.
Topics: Animals; Ascorbic Acid; Cardiotonic Agents; Cell Membrane; Dipyridamole; Ferrous Compounds; Humans; Kinetics; Lipid Peroxidation; Liver; Malondialdehyde; Mopidamol; Pyrimidines; Rats; Species Specificity; Vitamin E | 1992 |
[Disorders of organic hemodynamics of the liver and their correction in suppurative cholangitis].
Topics: Acute Disease; Animals; Aprotinin; Ascorbic Acid; Aspirin; Cholangitis; Cholestasis; Dextrans; Dipyridamole; Drainage; Drug Combinations; Heparin; Humans; Liver Circulation; Male; Microcirculation; Pentoxifylline; Pyridinolcarbamate; Rats; Rutin; Suppuration; Ultrasonography; Xanthinol Niacinate | 1991 |
[Persistent O2 multistep process against regulatory hypotension].
Topics: Aged; Ascorbic Acid; Blood Pressure Determination; Dipyridamole; Female; Head; Humans; Hypotension; Hypotension, Controlled; Male; Methods; Middle Aged; Neck; Nicotinic Acids; Oxygen Consumption; Oxygen Inhalation Therapy; Regional Blood Flow; Thiamine; Time Factors | 1973 |
[Investigations in multi-step-therapy of cancer (according to M. v. Ardenne) in animal experiments (author's transl)].
Topics: Animals; Ascorbic Acid; Benzopyrenes; Carcinoma; Carcinoma, Ehrlich Tumor; Dipyridamole; Female; Glucose; Hyperbaric Oxygenation; Male; Methods; Mice; Neoplasms, Experimental; Rats; Sarcoma, Experimental; Sarcoma, Yoshida; Vitamin A; Vitamin B Complex | 1974 |
Inhibition of lipid peroxide formation in mitochondria and fatty acid emulsions by 2,6-bis-(diethanolamino)-4,8-dipiperidino-pyrimido-(5,4-d)-pyimidine.
Topics: Animals; Ascorbic Acid; Cysteine; Depression, Chemical; Dipyridamole; Emulsions; Fatty Acids; Glutathione; In Vitro Techniques; Iron; Lipids; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Peroxides; Phospholipids; Rats; Stimulation, Chemical; Ultraviolet Rays | 1969 |
[Use of disaggregants in treating diabetic retinopathy].
Topics: Ascorbic Acid; Aspirin; Calcium Dobesilate; Diabetic Angiopathies; Diabetic Retinopathy; Dipyridamole; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Humans; Pentoxifylline; Platelet Aggregation; Rutin; Thrombelastography; Vision, Ocular | 1984 |
Glutaraldehyde treated bovine pericardium: changes in calcification due to vitamins and platelet inhibitors.
Topics: Animals; Ascorbic Acid; Aspirin; Biological Transport; Bioprosthesis; Calcinosis; Calcium; Calcium Phosphates; Cattle; Dipyridamole; Drug Combinations; Fixatives; Glutaral; Microscopy, Electron, Scanning; Pericardium; Platelet Aggregation Inhibitors; Pyridoxine; Vitamin E; Vitamins | 1997 |
[Substantiation of complex surgical treatment of inguinal hernia in children based on pathogenetic criteria].
Topics: Age Factors; Antioxidants; Ascorbic Acid; Aspirin; Blood-Testis Barrier; Child; Dipyridamole; Hernia, Inguinal; Humans; Hyperbaric Oxygenation; Infant; Infant, Newborn; Inosine Diphosphate; Ischemia; Male; Microcirculation; Platelet Aggregation Inhibitors; Postoperative Care; Testis; Vasodilator Agents | 1998 |
Treatment of glomerular endothelial dysfunction in steroid-resistant nephrosis with Ganoderma lucidum, vitamins C, E and vasodilators.
Topics: Adrenal Cortex Hormones; Angiotensin II; Ascorbic Acid; Calcium Channel Blockers; Dipyridamole; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Enalapril; Endothelial Cells; Glutathione; Humans; Kidney Function Tests; Kidney Glomerulus; Malondialdehyde; Nephrosis; Oxidative Stress; Phytotherapy; Plants, Medicinal; Platelet Aggregation Inhibitors; Proteinuria; Reishi; Renal Circulation; Treatment Outcome; Vasodilator Agents; Vitamin E | 2003 |